 Capricor Therapeutics CAPR a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment or prevention of serious diseases, today announced that it will host a Key Opinion Leader KOL call on the cardiac complications of DMD on Wednesday, April 15, 2020 at 1:30 pm Eastern Time. The call will feature a presentation by key opinion leader Michael Taylor, M.D., Ph.D. Cincinnati Childrens Hospital, Director of Advanced Imaging Innovation. Dr. Taylor will provide an overview of Duchenne muscular dystrophy, particularly focusing on the cardiac complications of the disease, its progression and current cardiac treatment options. 